Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators
NCT ID: NCT05932719
Last Updated: 2023-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2022-12-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Data collection will focus on the analysis of 2 specific pathologies for French patients in the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System
NCT04616950
The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric Cancer
NCT05130710
Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis
NCT04384926
Allocating Resources for Cancer Care in Times of the Sars-CoV-2 Outbreak. Health Care Research
NCT05479292
Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence
NCT04597294
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peritoneal Carcinosis
Patients hospitalized for peritoneal carcinosis between 2017 and 2020.
COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.
The following items will be collected
* Diagnostic date
* Diagnostic stage
* Date of surgery
* Date of surgery appointment
* First antineoplastic treatment date
* Last antineoplastic treatment date
* Number of treatment cycles recommanded by MDTM
Hepatocellular Carcinoma
Patients hospitalized for hepatocellular carcinoma between 2017 and 2020.
COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.
The following items will be collected
* Diagnostic date
* Diagnostic stage
* Date of surgery
* Date of surgery appointment
* First antineoplastic treatment date
* Last antineoplastic treatment date
* Number of treatment cycles recommanded by MDTM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.
The following items will be collected
* Diagnostic date
* Diagnostic stage
* Date of surgery
* Date of surgery appointment
* First antineoplastic treatment date
* Last antineoplastic treatment date
* Number of treatment cycles recommanded by MDTM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Lyon sud, Hospices civils de Lyon
Pierre-Bénite, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL20_0697
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.